High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

Rachel Anderson; Marc A. Pfeffer; Jens Jakob Thune; John J.V. McMurray; Robert M. Califf; Eric J. Velazquez; Harvey D. White; Jean L. Rouleau; Hicham Skali; Aldo Maggioni; Scott D. Solomon

doi:10.1016/j.ahj.2007.11.016

Related publications

Article2005

VALIANT (VALsartan In Acute myocardial iNfarcTion) trial

Aldo Maggioni, Gianna Fabbri

Article2000

Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

Marc A. Pfeffer, John J.V. McMurray, Alain Leizorovicz, Aldo Maggioni, Jean‐Lucien Rouleau, Frans Van de Werf, Marc Henis, Eric Neuhart, Paul Gallo, Susan Edwards, Mary Ann Sellers, Eric J. Velazquez, Robert M. Califf

Article2006

Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

Shelby D. Reed, John J.V. McMurray, Eric J. Velazquez, Kevin A. Schulman, Robert M. Califf, Lars Køber, Aldo Maggioni, Frans Van de Werf, Harvey D. White, Rafael Díaz, Mareev VIu, Ján Murín

Article2003

VALsartan In Acute Myocardial Infarction (VALIANT) Trial: Baseline Characteristics in Context

Eric J. Velazquez, Marc A. Pfeffer, John J.V. McMurray, Aldo Maggioni, Jean‐Lucien Rouleau, Frans Van de Werf, Lars Køber, Harvey D. White, Karl Swedberg, Jeffrey D. Leimberger, Paul Gallo, Mary Ann Sellers, Susan Edwards, Marc Henis, Robert M. Califf

Article2010

Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

Kent R. Nilsson, Sana M. Al‐Khatib, Yi Zhou, Karen S. Pieper, H. D. White, Aldo Maggioni, Lars Køber, Christopher B Granger, E. F. Lewis, John J.V. McMurray, Robert M. Califf, E. J. Velazquez